ACE inhibitor-induced cough and bronchospasm. Incidence, mechanisms and management

Drug Safety

Volumn 15, Issue 1, 1996, Pages 72-78

  Overlack, Axel ^a,b  

^a NONE

^b Gastroenterologie am Burgweiher   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

CAPTOPRIL; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; ENALAPRIL; KININ;

AIRWAY OBSTRUCTION; ASTHMA; BRONCHOSPASM; COUGHING; DOSE TIME EFFECT RELATION; HUMAN; INCIDENCE; PHARMACOGENETICS; PRIORITY JOURNAL; REVIEW; RISK FACTOR;

EID: 0029950978     PISSN: 01145916     EISSN: None     Source Type: Journal    
DOI: 10.2165/00002018-199615010-00006     Document Type: Review

References (71)

1. Jayarajan A, Prakash O. Cough syncope induced by enalapril. Chest 1993; 103: 327-8
2. Israili ZH, Hall D. Cough and angioneurotic edema associated with angiotensin-converting enzyme inhibitor therapy. Ann Intern Med 1992; 117: 234-42
3. Todd PA, Heel RC. Enalapril: a review of its pharmacodynamic and pharmacokinetic properties and therapeutic use in hypertension and congestive heart failure. Drugs 1986; 31: 198-248
4. Coulter DM, Edwards IR. Cough associated with captopril and enalapril. BMJ 1987; 294: 1521-3
5. Inman WHW, Rawson NSB, Wilton LV, et al. Postmarketing surveillance of enalapril. I: Results of prescription-event monitoring. BMJ 1988; 297: 826-9
6. Chalmers D, Whitehead A, Lawson DH. Postmarketing surveillance of captopril for hypertension. Br J Clin Pharmacol 1992; 34: 215-23
7. Fletcher AE, Palmer AJ, Bulpitt CJ. Cough with angiotensin converting enzyme inhibitors: how much of a problem? J Hypertens 1994; 12 Suppl. 2: S43-7
8. Ravid D, Lishner M, Lang R, et al. Angiotensin-converting enzyme inhibitors and cough: a prospective evaluation in hypertension and in congestive heart failure. J Clin Pharmacol 1994; 34: 1116-20
9. Simon SR, Black HR, Moser M, et al. Cough and ACE inhibitors. Arch Intern Med 1992; 152: 1698-1700
10. Sebastian JL, McKinney WP, Kaufman J, et al. Angiotensin-converting enzyme inhibitors and cough. Prevalence in an outpatient medical clinic population. Chest 1991; 99: 36-9
11. Fletcher AE, Bulpitt CJ, Chase DM, et al. Quality of life with three antihypertensive treatments: cilazapril, atenolol, nifedipine. Hypertension 1992; 19: 499-507
12. Yeo WW, Maclean D, Richardson PJ, et al. Cough and enalapril: assessment by spontaneous reporting and visual scale under double-blind conditions. Br J Clin Pharmacol 1991; 31: 356-9
13. Lacourciere Y, Brunner H, Irwin R, et al. Effects of modulators of the renin-angiotensin-aldosterone system on cough. J Hypertens 1994; 12: 1387-93
14. Reisin L, Schneeweiss A. Complete spontaneous remission of cough induced by ACE inhibitors during chronic therapy in hypertensive patients. J Hum Hypertens 1992; 6: 333-5
15. Yeo WW, Foster G, Ramsay LE. Prevalence of persistent cough during long-term enalapril treatment: controlled study versus nifedipine. Q J Med 1991; 293: 763-70
16. Os I, Bratland B, Dahlöf B, et al. Female preponderance for lisinopril-induced cough in hypertension. Am J Hypertens 1994; 7: 1012-5
17. Wood R. Bronchospasm and cough as adverse reactions to the ACE inhibitors captopril, enalapril and lisinopril: a controlled retrospective cohort study. Br J Clin Pharmacol 1995; 39: 265-70
18. Berkin KE, Ball SG. Cough and angiotensin converting enzyme inhibition. BMJ 1988; 296: 1279-80
19. Sorooshian M, Eynon CA, Webb DJ, et al. Cough associated with ACE inhibitors: increased frequency in renal failure. Eur J Int Med 1991; 2: 15-7
20. Goldszer RC, Lilly LS, Solomon HS. Prevalence of cough during angiotensin-converting enzyme inhibitor therapy. Am J Med Sci 1988; 85: 887
21. Strocchi E, Valtancoli G, Ambrosioni E. The incidence of cough during treatment with angiotensin converting enzyme inhibitors. J Hypertens 1989; 7 Suppl. 6: S308-9
22. Puolijoki H, Nieminen M, Moilanen E, et al. Cough induced by enalapril but not by captopril. Eur Respir J 1989; 2: 289-91
23. Saruta T, Nishikawa K. Characteristics of a new angiotensin converting enzyme inhibitor: delapril. Am J Hypertens 1991; 4: S23-8
24. Sharif MN, Evans BL, Pylypchuk GB. Cough induced by quinapril with resolution after changing to fosinopril. Ann Pharmacother 1994; 28: 720-2
25. Overlack A, Müller B, Schmidt L, et al. Airway responsiveness and cough induced by angiotensin converting enzyme inhibition. J Hum Hypertens 1992; 6: 387-92
26. Sala H, Abad J, Juanmiquel LI, et al. Captopril and bronchial reactivity. Postgrad Med J 1986; 62 Suppl. 1: 76-7
27. Bertoli L, Fusco M, LoCicero S, et al. Influence of ACE inhibition on pulmonary haemodynamics and function in patients in whom beta-blockers are contraindicated. Postgrad Med J 1986; 62 Suppl. 1: 47-51
28. Peacock AJ, Matthews AW. The effect of captopril on pulmonary haemodynamics and lung function in patients with chronic airflow obstruction [letter]. Thorax 1986; 41: 225
29. Riska H, Stenius-Aarniala B, Sovijarvi ARA. Comparison of the efficacy of an ACE-inhibitor and a calcium channel blocker in hypertensive patients: a preliminary report. Postgrad Med J 1986; 62 Suppl. 1: 52-3
30. Kaufman J, Casanova JE, Riendl P, et al. Bronchial hyperreactivity and cough due to angiotensin-converting enzyme inhibitors. Chest 1989; 95: 544-8
31. Mue S, Tamura G. Yumauchi K, et al. Bronchial response to enalapril in asthmatic, hypertensive patients. Clin Ther 1990; 12: 335-43
32. Popa V. Captopril-related (and induced?) asthma. Am Rev Respir Dis 1987; 136: 999-1000
33. Semple PF, Herd GW. Cough and wheeze caused by inhibitors of angiotensin converting enzyme. N Engl J Med 1986; 314: 61
34. Goh TC, Ong YY. Bronchial hyperreactivity induced by angiotensin converting enzyme inhibitor. Singapore Med J 1991; 32: 183-4
35. Lunde H, Hedner T, Samuelsson O, et al. Dyspnoea, asthma, and bronchospasm in relation to treatment with angiotensin converting enzyme inhibitors. BMJ 1994; 308: 18-21
36. Bucknall CE, Neilly JB, Carter R, et al. Bronchial hyperreactivity in patients who cough after receiving angiotensin converting enzyme inhibitors. BMJ 1988; 296: 86-8
37. Andersson RGG, Persson K. ACE inhibitors and their influence on inflammation, bronchial reactivity and cough. Eur Heart J 1994; 15 Suppl. C: 52-6
38. Hinojosa M, Quirce S, Puyana J, et al. Bronchial hyperreactivity and cough induced by angiotensin converting enzyme-inhibitor therapy. J Allergy Clin Immunol 1990; 85: 818-9
39. Boulet LP, Milot J, Lampron N, et al. Pulmonary function and airway responsive-ness during long-term therapy with captopril. JAMA 1989; 261: 413-6
40. Dixon CMS, Fuller RW, Barnes PJ. The effect of an angiotensin converting enzyme inhibitor, ramipril, on bronchial responses to inhaled histamine and bradykinin in asthmatic subjects. Br J Clin Pharmacol 1987; 23: 91-3
41. Fuller RW, Choudry NB. Increased cough reflex associated with angiotensin converting enzyme inhibitor cough. BMJ 1987; 295: 1025-6
42. Morice AH, Lowry R, Brown MJ, et al. Angiotensin-converting enzyme and the cough reflex: Lancet 1987; 11: 1116-8
43. McEwan JR, Choudry N, Street R, et al. Change in cough reflex after treatment with enalapril and ramipril. BMJ 1989; 299: 13-6
44. Buck SH, Burks TF. The neuropharmacology of capsaicin: review of some recent observations. Pharmacol Rev 1986; 38: 179-226
45. Sant' Ambrogio G. Afferent pathways for the cough reflex. Bull Eur Physiopathol Respir 1987; 23 Suppl. 10: 19S-23S
46. Kellstein DE, Price DD, Hayes RL, et al. Evidence that substance P selectively modulates C-fiber-evoked discharges of dorsal horn nociceptive neurons. Brain Res 1990; 526: 291-8
47. Barnes PJ. Neuropeptides in human airways: functional and clinical implications. Am Rev Respir Dis 1987; 136: 77-83
48. Casceiri MA, Bull Hg, Mumford RA, et al. Carboxyl-terminal tripeptidyl hydrolysis of substance P by purified rabbit lung angiotensin-converting enzyme and the polentiation of substance P activity in vivo by captopril and MK-422. Mol Pharmacol 1984; 25: 287-93
49. Thysell H, Andersson KE, Andersson SI, et al. Angiotensin-converting enzyme inhibition, cough and the serum concentration of substance P. Eur J Clin Pharmacol 1988; 34: 649-50
50. Erdös EG. The angiotensin I converting enzyme. Fed Proc 1977; 36: 1760-5
51. Fuller RW, Warren JB, McCusker M, et al. Effect of enalapril on the skin response to bradykinin in man. Br J Clin Pharmacol 1987; 23: 88-90
52. Fuller RW, Dixon CMS, Cuss FMC, et al. Bradykinin-induced bronchoconstriction in humans: mode of action. Am Rev Respir Dis 1987; 135: 176-80
53. Ujiie Y, Sekizawa K, Katsumata U, et al. Bradykinin-induced cough reflex markedly increases in patients with cough associated with captopril or enalapril [abstract]. Am Rev Respir Dis 1990; 141: A923
54. Puolijoki H, Nieminen MM, Moilanen E, et al. Bradykinin and eicosanoids in enalapril-induced cough [abstract]. Am Rev Respir Dis 1990; 141: A918
55. Gradman A, Arcuri KE, Goldberg AI, et al. A randomized, placebo-controlled, double-blind, parallel study of various doses of losartan potassium compared with enalapril maleate in patients with essential hypertension. Hypertension 1995; 25; 1345-50
56. Hartung HP, Heininger K, Schäfer B, et al. Substance P and astrocytes: stimulation of the cyclooxygenase pathway of arachidonic acid metabolism. FASEB J 1988; 2: 48-51
57. Coleridge HM, Coleridge JC, Ginzel KH, et al. Stimulation of 'irritant' receptors and afferent C-fibres in the lungs by prostaglandins. Nature 1976; 264: 451-3
58. Greenberg R, Osman Jr GH, O'Keefe HH, et al. The effects of captopril (SQ 14.225) on bradykinin-induced bronchoconstriction in the anaesthetised guinea pig. Fur J Pharmacol 1979; 57: 287-94
59. Rossoni G, Ommi C, Vigano T, et al. Bronchoconstriction by histamine and bradykinin in guinea pigs: relationship to thromboxane A2 generation and the effect of aspirin. Prostaglandins 1980; 20: 547-57
60. Nicholls MG, Gilchrist NL. Sulindac and cough induced by converting enzyme inhibitors [letter]. Lancet 1987; 1: 872
61. Gilchrist NL, Richards AM, March M, et al. Effect of sulindac on angiotensin converting enzyme inhibitor-induced cough: randomised placebo-controlled double-blind cross-over study. J Hum Hypertens 1989; 3: 451-5
62. Yeo WW, Ramsey LE, Morice AH. Ace inhibitor cough: a genetic link [letter]? Lancet 1991; 337: 187
63. Rigat B, Hubert C, Alhenc-Gelas F, et al. An insertion deletion polymorphism in the angiotensin I-converting enzyme gene accounting for halt of the variance of serum enzyme levels. J Clin Invest 1990; 86: 1343-6
64. Furuya K, Yamaguchi E, Hirabayashi T, et al. Angiotensin-I-converting enzyme gene polymorphism and susceptibility to cough [letter]. Lancet 1994; 343: 354
65. Kreft-Jais C, Laforest L, Bonnardeaux A, et al. ACE inhibitors, cough, and genetics [letter]. Lancet 1994; 343: 740
66. Chadwick AG, Yeo WW, Higgins KS, et al. ACE inhibitors, cough, and genetics. Lancet 1994; 343: 740-1
67. Fogari R, Zoppi A, Tettamanti F, et al. Effects of nifedipine and indomethacin on cough induced by angiotensin-converting enzyme inhibitors: a double-blind, randomized, cross-over study. J Cardiovasc Pharmacol 1992; 19: 670-3
68. Eujita T, Yamashita N, Yamashita K. Effect of indomethacin on antihypertensive action of captopril in hypertensive patients. Clin Exp Hypertens 1981; 3: 939-52
69. Cazzola M, Matera MG, Liccardi G, et al. Theophylline in the inhibition of angiotensin-converting enzyme inhibitor-induced cough. Respiration 1993; 60: 212-5
70. Kamei J, Kasuya Y. The effect of hydrochlorothiazide on the enhanced coughing associated with treatment with enalapril. Eur J Pharmacol 1992; 213: 137-9
71. Hargreaves MR, Benson MK. Inhaled sodium cromoglycate in angiotensin-converting enzyme inhibitor cough. Lancet 1995; 345: 13-6